Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Antares Pharma (NQ: ATRS )

4.100 USD -0.020 (-0.49%)
Official Closing Price Updated: 4:26 PM EDT, Apr 9, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Antares Pharma

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
First Week of November 19th Options Trading For Antares Pharma (ATRS)
Investors in Antares Pharma Inc. (ATRS) saw new options begin trading this week, for the November 19th expiration.. 
Tags Stocks
From Market News Video
The Daily Biotech Pulse: Roxadustat Delay For FibroGen, AstraZeneca, Decision Day For KemPharm, NanoViricides Jumps On COVID-19 Drug Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ASLN GMTX KRYS
From Benzinga
Recap: Antares Pharma Q4 Earnings
Shares of Antares Pharma (NASDAQ:ATRS) were unchanged after the company reported Q4 results. Quarterly Results Earnings ... 
Tags Earnings BZI/Recaps Benzinga
From Benzinga
Earnings Scheduled For March 2, 2021
Companies Reporting Before The Bell • Kopin (NASDAQ:KOPN) is expected to report quarterly loss at $0.01 per share on ... 
Tags SE BGS ITMR
From Benzinga
Analysts Forecast 10% Upside For The Holdings of XHE
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Antares Pharma's Earnings: A Preview
Antares Pharma (NASDAQ:ATRS) releases its next round of earnings this Tuesday, March 02. Get the latest predictions in Benzinga's ... 
Tags Earnings BZI/EP Benzinga
From Benzinga
The Week Ahead In Biotech (Feb. 28-March 6): KemPharm, Gilead FDA Decisions and More Earnings
Biotech stocks extended their losses in the week ended Feb. 26 amid continued weakness in the broader market. Earnings came in thick and ... 
Tags CLPT ARCT ADAG
From Benzinga
The Daily Biotech Pulse: Novavax Vaccine Supply Deal, Orphan Drug Designation For Travere, COVID-19 Boost For Quidel, Opko
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags News Benzinga PFE
From Benzinga
The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags GOVX GSK VERU
From Benzinga
The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags LGND BLK Penny Stocks
From Benzinga
3 Top Stocks Trading Under $5 a Share
These interesting low-cost stocks have the opportunity to grow. 
Tags OPK FLNT Market News
From Motley Fool
3 Top Stocks Under $5
These companies offer more potential than the stock price might indicate. 
Tags NOK ATRS Market News
From Motley Fool
The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Health Care ADMS SPRO
From Benzinga
The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings
Biotech stocks continued to sway to the tunes of the broader market in the week ended Oct. 30, which succumbed to geopolitical and ... 
Tags BLFS ADMA CNCE
From Benzinga
Analysts See 28% Gains Ahead For RYJ
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
4 Penny Stocks To Buy According To Analysts; 1 With A 189% Target
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Add Up The Parts: VHT Could Be Worth $231
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
First Week of ATRS May 2021 Options Trading
Investors in Antares Pharma Inc. (ATRS) saw new options begin trading this week, for the May 2021 expiration.. 
Tags Stocks
From Market News Video
Analysts Forecast 13% Upside For ESML
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Antares Pharma Inc (ATRS) Q2 2020 Earnings Call Transcript
ATRS earnings call for the period ending June 30, 2020. 
Tags Market News ATRS
From Motley Fool
Why Antares Pharma's Stock Is Trading Higher Today
Antares Pharma (NASDAQ: ATRS) shares are trading higher on Monday after the company announced a deal with Lunatus Global to distribute ... 
Tags Market News Benzinga why it's moving
From Benzinga
Analysts Anticipate ESML To Hit $28
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Analysts Anticipate 15% Upside For VTWG
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Why Is This Fast-Growing Biotech So Undervalued?
Why is a fast-growing company making one of the best testosterone replacement therapies on the market so underappreciated by investors? 
Tags MYL Market News ATRS
From Motley Fool
70 Biggest Movers From Yesterday
Gainers Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) shares jumped 130% to close at $17.85 on Tuesday after the company announced ... 
Tags Benzinga CODI ASC
From Benzinga
Antares Pharma Inc (ATRS) Q1 2020 Earnings Call Transcript
ATRS earnings call for the period ending March 31, 2020. 
Tags Market News ATRS
From Motley Fool
Why Antares Pharma Is Crashing 12.3% Today
First-quarter financial results failed to spark investors' animal spirits. 
Tags ATRS Market News MYL
From Motley Fool
51 Stocks Moving In Tuesday's Mid-Day Session
Gainers Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) shares climbed 129% to $17.76 after the company announced it will be ... 
Tags NCLH WRK AKBA
From Benzinga
The Daily Biotech Pulse: Bio-Rad's Coronavirus Test Gets EUA, Beat-and-Raise Quarter From GenMark, Adverum's Positive Gene Therapy Readout
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting ... 
Tags KPTI Benzinga IMRA
From Benzinga
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
Biotech stocks started last weekon a strong note but the upward momentum slowed through the week. The week saw a slew of earnings ... 
Tags MNK TWST SYRS
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.